BEUDAMED
    19 results · 21ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    CHASE PHRENIC NERVE PAD

    FDA 510(k)
    FDA Class 2 ·Cardiovascular

    NA

    FDA UDI
    KEY SURGICAL, INC.·10849771048739·K-Wires, Double trocar, .028-inch (0.7mm) diame...

    mahe medical GmbH

    FDA UDI
    mahe medical gmbh·04050659483910·K-Wire w. double end trocarpoint _x000D_...

    K-Wire w. double end trocarpoint 0.70mm/152mm, 6 pcs./unit

    FDA UDI
    mahe medical gmbh·EMAHKM710210·K-Wire w. double end trocarpoint 0.70mm...

    Ortho Organizers

    FDA UDI
    Ortho Organizers, Inc.·00190707048631·WELDABLE LINGUAL BUTTON - CURVED

    AUTO-CLIP

    FDA 510(k)
    FDA Class 2 ·Cardiovascular

    JO Agapé Personal Lubricant

    FDA 510(k)
    FDA Class 2 ·Obstetrics/Gynecology

    ZMR®

    FDA UDI
    Zimmer, Inc.·00889024159006·

    ZMR®

    FDA UDI
    Zimmer, Inc.·00889024158993·

    NexGen®

    FDA UDI
    Zimmer, Inc.·00889024214712·

    NexGen®

    FDA UDI
    Zimmer, Inc.·00889024214736·

    NexGen®

    FDA UDI
    Zimmer, Inc.·00889024214743·

    NexGen®

    FDA UDI
    Zimmer, Inc.·00889024214705·

    NexGen®

    FDA UDI
    Zimmer, Inc.·00889024214750·

    NexGen®

    FDA UDI
    Zimmer, Inc.·00889024214729·

    CHARGING SYSTEM

    FDA Adverse Event
    Injury ·ST. JUDE MEDICAL - NEUROMODULATION·Product code LGW·February 15, 2013

    RESTORE RECHARGEABLE NEUROSTIMULATOR

    FDA Adverse Event
    Malfunction ·MDT PUERTO RICO OPERATIONS CO., JUNCOS·Product code LGW·January 6, 2011

    NATURALYTE

    FDA Adverse Event
    Injury ·FRESENIUS MEDICAL CARE NORTH AMERICA·Product code KPO·July 8, 2014

    Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

    FDA Enforcement
    Class II ·Terminated·St Jude Medical Inc.·October 25, 2017